Text Size

2010 Annual Benefit Most Successful Yet

A record attendance of 375 guests arrived on January 27th at the historic Palace Hotel in San Francisco to “Celebrate the Scientists” whose research holds promise for a cure for glaucoma.

Total proceeds from the gala exceeded $475,000 with a record level of Table Sponsorships, Ticket Sales and Contributions. Event Co-Chairs Nobuko Saito Cleary and Gary Cleary, PharmD, PhD, worked tirelessly to advance the important work of Glaucoma Research Foundation, as did the effective members of their Event Committee.

Ambassadors Circle Co-Hosts Mona and Ed Zander welcomed sponsors and their guests to a lovely reception in the hotel’s French Parlor. Ed’s sister Risa from New York joined them, emphasizing the Zander family’s personal connection to glaucoma and commitment to cure the disease.

Research Overview Co-Hosts Deirdre Porter and Bradford Hall greeted guests at the annual research update. Catalyst For a Cure Principal Investigators David Calkins, PhD (Vanderbilt University), Philip Horner, PhD (University of Washington), Nicholas Marsh-Armstrong, PhD (Johns Hopkins University) and Monica Vetter, PhD (University of Utah) reported on their progress over the last year. UBS sponsored this year’s Research Overview through the efforts of GRF Board member H. Allen Bouch.

The Shaffer Prize for Innovative Glaucoma Research was presented to Kate E. Keller, PhD, of Casey Eye Institute in Portland, OR, recognizing Dr. Keller’s investigation of genetic techniques to increase fluid outflow to lower pressure in patients with primary open-angle glaucoma. Outstanding volunteer Andi Mallinckrodt received the President’s Award from Thomas M. Brunner for leadership as well as her creative and beautiful decorative contributions to GRF events, including every Benefit.

This year’s Catalyst Award recipient was Jeffrey B. Kindler, Chief Executive Officer and Chairman of Pfizer, whose generous sponsorship led increased support for the Benefit from the corporate ophthalmic community. Accepting on behalf of Mr. Kindler was Dr. Michael Berelowitz, Senior Vice President of Clinical Development & Medical Affairs in Pfizer’s Specialty Care Business Unit. A number of dignitaries paid tribute to GRF’s leadership. Honorary California Chair Governor Arnold Schwarzenegger welcomed guests by video. And Consul General of Japan Yasumasa Nagamine, honored guest of our Event Co-Chairs, made gracious personal remarks at the dinner.

A highlight of the event was a musical salute and tribute by Roger McGuinn, co-founder of The Byrds and National Honorary Chairman of the Catalyst For a Cure Campaign. His performance of four classic songs brought the crowd to its feet.

Once again Board members June Behrendt and Linda Linck co-chaired the Silent Auction during the President’s Reception, which built enthusiasm among many active bidders. Please save the date for next year - Wednesday, January 26, 2011!

Last reviewed on February 26, 2015

Was this helpful? Yes No